| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |